(Press-News.org) New Rochelle, NY, June 2, 2011—Biotech scientists are working on novel protein kinase inhibitors that are targeting a host of conditions ranging from atherosclerosis to neurodegenerative diseases, reports Genetic Engineering & Biotechnology News (GEN). Recent developments in the protein kinase inhibitor field include innovative paradigms for drug development, improved inhibitor profiling and selectivity strategies, and the expansion of disease targets (e.g., Alzheimer disease and traumatic brain injury), according to the June 1 issue of GEN (http://www.genengnews.com/gen-articles/kinase-inhibitor-obstacles-falling/3674/).
"Protein kinases underlie important cellular activities such as proliferation, metabolism, apoptosis, and differentiation, among others," says John Sterling, Editor in Chief of GEN. "They provide an excellent opportunity for a number of promising new drug products."
Researchers at ArQule, for example, are focusing on the inactive state of kinases. They carried out structural and functional studies on inhibitors of the c-Met receptor tyrosine kinase that is implicated in several cancers. The team subsequently co-crystallized their own small molecule inhibitor with inactive c-Met and reportedly discovered a conformation that is distinct from published kinase structures.
Scientists at Celgene are refining the company's in-house kinase selectivity strategy. They used Caliper Life Sciences' ProfilerPro kinase selectivity assay to find selectivity snapshots they were seeking.
INFORMATION:
Also covered in the GEN article is protein kinase inhibitor research taking place at Genentech, Merck Sharpe & Dohme, and the Harvard NeuroDiscovery Center.
For a copy of the June 1 issue of GEN, please call (914) 740-2122, or email: ebicovny@liebertpub.com
Genetic Engineering & Biotechnology News (GEN) has retained its position as the number one biotech publisher around the globe since its launch in 1981. GEN publishes a print edition 21 times a year and has additional exclusive editorial content online, such as news and analysis, podcasts, webinars, polls, videos, and application notes. GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
GEN reports on advances in novel protein kinase inhibitor development
2011-06-03
[Attachments] See images for this press release:
ELSE PRESS RELEASES FROM THIS DATE:
Tesco Real Food Reveals Biggest and Best English Strawberry Crop in Twenty Years
2011-06-03
Tesco Real Food has announced that Britain's spring heat wave has led to the biggest and best quality English strawberry crop for 20 years growers have reported.
The glut of English strawberries - considered by experts to be the best in the world - will result in an estimated 50 per cent reduction in UK retailers bringing in imports.
Experts say that Britain's warmer than usual March and April heat wave produced perfect growing conditions resulting in the crop being at least two weeks earlier than usual and the extra sunshine has also increased sugar levels making ...
Scottsboro Hotel Lets Guests Book Now and 15% Savings During The Great Getaway
2011-06-03
The Hampton Inn & Suites Hotel Scottsboro is now offering the perfect summer package. The Great Getaway package includes offering guest an additional 15% off Hampton's Best Available Rates for guests who book their stay now through August 22, 2011. Visits must take place by September 5, 2011.
Among other Scottsboro Alabama Hotels, The Hampton Inn & Suites is the premier place to stay in the area. The property's features and amenities include:
- Complimentary high speed Internet access
- Free hot breakfast
- Fitness center and outdoor pool
- Boat slip parking
- ...
In the lab and clinic, VCU Massey develops a new therapy for blood cancers
2011-06-03
Richmond, Va. (June 2, 2011) – Clinical researchers at VCU Massey Cancer Center have successfully completed a Phase I clinical trial evaluating a combination of the drugs Bortezomib and Alvocidib in patients with relapsed or refractory blood cancers, paving the way for a Phase II clinical trial to test the safety and effectiveness of the new therapy.
Reported in the journal Clinical Cancer Research, the study determined the maximum tolerated dose with acceptable side effects for this novel drug combination. The trial represented the first time a proteasome inhibitor such ...
Use of clot-busting drug for US stroke patients doubled from 2005 to 2009
2011-06-03
CINCINNATI—In a review of nationwide hospital databases, University of Cincinnati (UC) emergency medicine and neurology researchers have found that the rate of treatment with the standard therapy for acute ischemic stroke patients has doubled since 2005.
Their paper, "Recombinant Tissue-Type Plasminogen Activator Use for Ischemic Stroke in the United States," is published online ahead of print in the journal Stroke. The study estimates between 23,800 and 36,000 U.S. patients received rtPA treatment in 2009—up from between 10,800 to 12,600 in 2004.
Since its approval ...
Developmental disease is recreated in an adult model
2011-06-03
(Cincinnati, OH) – An IRSF funded study published today in the journal Science has shown that the childhood disorder Rett syndrome, can be reestablished in adult animals by "switching off" a critical disease causing gene in healthy adult animals. The gene was "switched off" in adult mice by use of a sophisticated genetic trick, resulting in the appearance of behaviors typically seen in Rett syndrome. The leading author Christopher McGraw, MD/PhD student, carried out the study in the laboratory of Dr. Huda Zoghbi, a renowned neuroscientist based at Baylor College of Medicine, ...
Business Monitor International Reveals Report on Dry-Bulk Shipping Sector
2011-06-03
Business Monitor International has announced the launch of its special report on the dry-bulk shipping sector called 'Dry-Bulk Shipping in Troubled Waters as Glut of Vessels Soaks up Demand'.
The shipping industry analysis report provides an in-depth overview of the challenges that the global dry-bulk shipping sector faces in 2011, with a particular focus on the sector's ability to tackle its current overcapacity crisis.
The dry-bulk shipping sector's woes are expected to continue for some time to come, as dropping rate have already lead to Korea Line Corp filing ...
Microstructure-induced biomechanical responses of dragonfly wing veins
2011-06-03
Wang's research team discovered the sandwich microstructure of dragonfly wing veins [Wang et al. Compos Sci & Technol, 2008; 68: 186-192] and recently revealed the organic junction between these longitudinal veins and membranes of the dragonfly wing [Chen and Wang et al. Chinese Sci Bull, 2011; 56: 1658-1660]. Based on observed microstructural model and previously reported model about the main longitudinal veins and membrane, in which the former is based on the tubular model with sandwich structure in thickness of tubular, and the latter is based on the sample tubular model ...
British Airways Launches Luxury Sale
2011-06-03
British Airways is cutting its fares by up to 29 per cent in business class and up to 60 per cent in its First Class cabin in its Luxury Sale for bookings made between May 26 and June 21, 2011. Over 80 destinations are included in the sale based on various travel dates from June 9 to December 31, 2011.
Customers can enjoy savings of up to 29 per cent on business class flights to Grenada and up to 24 per cent on business class flights to Kingston in Jamaica. Great value holiday packages are also available including holidays to Jamaica at the 4.5* Hilton Rose Hall Resort ...
Helping Latinos quit smoking: Miriam Hospital studies offers new insight
2011-06-03
PROVIDENCE, R.I. – Latinos looking to quit smoking are more successful when they have a significant other and partner support, say researchers from The Miriam Hospital's Centers for Behavioral and Preventive Medicine. According to the study, published in the May/June issue of the American Journal of Health Promotion, this support can also buffer the demonstrated negative effect that depression can have on smoking cessation.
Latinos are the largest, fastest growing minority population in the country, based on U.S. Census data. Smoking prevalence among Latinos is 15.8 percent ...
Radisson Blu Paris Boulogne Official Partner of French Open Tennis Tournament
2011-06-03
Radisson Blu Paris Boulogne is welcoming one of the more exciting sport event in France, the Grand Slam tournament Rolland Garros, for the fifth year running.
Roland Garros is a part of the four annual Grand Slam tournaments and will be taking place until June 5th. The Radisson Blu Hotel Paris Boulogne is proud to be the official partner hotel of the event since its opening in 2006.
Being a partner hotel means that Radisson Blu Hotel Paris Boulogne will lodge several well-known players and sponsors such as Babolat, Nike, BNP Paribas or Head Sport.
"We are ...